Blog 11: Intervention Implementation and Evaluation
As a policy maker for health issues, an implementation that I will
address
Screening
to all pregnant women for tobacco use and all receive best practice cessation
counseling
This is a policy that should be implemented to all those
pregnant women’s or every woman in their communities should be reinforced to
go. Tobacco usage in general is already bad and screening could prevent it to
these women and to orient them. Also if a woman doesn’t smoke and she has high
levels of cotinine it is highly due to second hand smoking. This could be
caused by one of the determinants, environmental, such as her workplace or even
a member in the household which could be even prevented and leading to another
implementing program which is:
Education
programs for women/partners as well as health and social services providers.
As well as prenatal care services will be held, a short
term outcome of the program will be that since these workers know the sighs and
symptoms of preterm labors an the appropriate response they can share the
guidelines and labor assessment if the screening doesn’t look good before the
22 weeks pregnancy.
The
effectiveness of this implementation is considered secondary and tertiary since
they are directed to each person individually as well as a solution for the
aftermath. To show and prove its effectiveness is the amount of pregnant women
who come to get screened. If a group number of pregnant women are recorded per
community per week, it can be seen if it is effectiveness based on their
appointments and if they come. Also based on their screening and their cotinine
level if values of 10ng/mL or less is considered
no smoking, 10 ng/mL to 100 ng/mL are associated with light smoking or moderate
passive exposure, and levels above 300 ng/mL are seen in heavy smokers - more
than 20 cigarettes a day. In urine, values between 11 ng/mL and 30 ng/mL may be
associated with light smoking or passive exposure, and levels in active smokers
typically reach 500 ng/mL or more. Based on this data you can divide the women
into groups and based on their data you can know what statistics or
measurements you have to take.
For this to be implemented, I will like it to be a policy in their
community that for every woman pregnant, they should have a screening for
cotinine levels. During the 18 to 22 weeks. The barriers that will be
encountered is the social factor. Some women would not like to go to screening
or they will not go just because they don’t feel like it. To overcome this
issue, free screening could be offered or a minimal cost that they could afford
or create medias for it, and not sell it as a smoking propaganda. The
advertisement will be more for a check up and it could be free. Another barrier
is transportation. Some women due to economical issues, they can’t go to a
prenatal care; however, for this to be overcome, prenatal care services could
be placed into those communities for screening, prenatal care services and
educational programs that will follow up with the program. Another barrier that
could be encountered is the infrastructure (what is mentioned above) and also
the issue with the money. The money can be donated from potential action groups
that could make fundraisers or even get grants for this public health issue, as
well governmental support.
Once I have the barriers, the stakeholders that I will communicate
the information too will be:
-
The pregnant
mothers
-
Physician:
Neonatologist and Obstetricians and Gynecologists
-
Prenatal Care
Staff
-
National Institute
for Health and Clinical Excellence
The pregnant mothers will be the first one to talk to. Once they are
convinced, then we are able to talk to the other stakeholders for money,
services and more. My strategy for these pregnant women is to tell them that
the screening will be a way to check on their health and their baby. There
could also be educated forums that these women can go to. Another way of doing
it is these women have Medicaid meaning that their primary physicians for the
screening view should contact them. These will make them go, and with that we
can count the number of women who came and who didn’t for other extra measures
to take such as to see if they had trouble to come to the prenatal care
services or to educate them as to why screening is such an important thing to
do. Once that is done, we can contact the National Institute for Health and
Clinical Excellence for grants or any other action groups, and once money is
secured, prenatal care staff as well as physicians.
The evaluation for this effectiveness
for my intervention will be the total number of women in a community, and based
on that the number of pregnant women who go to these screenings based on their
appointment records and if they come. Based on that we can tell if it is
working or not and to see the other measures to take. Identify
one partner to coordinate the data collection and collate the data from the various
sources for the evaluation.